Bristol-Myers Squibb Warns Against Tutanota’s Mini-Tender Offer

Bristol-Myers Squibb (BMY) has released an update.

Bristol-Myers Squibb Company has alerted its shareholders to a mini-tender offer from Tutanota LLC, seeking to acquire up to 500,000 shares at $55.00 each. The company advises against its stockholders accepting this offer, which accounts for a minor fraction of its total shares. Shareholders are informed that they can withdraw previously tendered shares before the offer’s deadline on February 23, 2024, and that the company has no association with Tutanota or its offer.

For further insights into BMY stock, check out TipRanks’ Stock Analysis page.